4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000007
Options or other derivatives
- Chief Executive Officer acquired 163,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-10 | Grant or award : show line 1 in the form Stock option (right to buy) | +163,000 | 163,000 | D |
Loading xslF345X03/wf-form4_161316500956020.xml…